rxstat › Shortages › Icatibant

Icatibant shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 24, 2026

Icatibant has no current shortage reported in Canada. No active reports are on file.

An injection used to treat acute attacks of hereditary angioedema.

Products affected
0 / 1
Reports on file
1

Reports by product

Resolved
ICATIBANT INJECTION
10MG · SOLUTION · JAMP PHARMA CORPORATION
DIN 02547562 · ended Jul 23, 2026 · Disruption of the manufacture of the drug.

What's happening

There are no active shortage reports for Icatibant.

Icatibant is classified under “OTHER HEMATOLOGICAL AGENTS” (ATC B06AC).

Recent changes

Common questions

What is Icatibant used for?

An injection used to treat acute attacks of hereditary angioedema.

When will Icatibant be back in stock in Canada?

Icatibant has no active shortage; supply is normal per Health Canada reports.

Why is Icatibant in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.